IFNG and neoplasm: Blocking TGF-β1 and TGF-α2 significantly increased the Th1 immune response, upregulated IFN-γ production, and increased T-bet expression, a key transcription factor determining Th1 cell differentiation in tumor-infiltrating CD8+ T cells.